On Friday, Regenxbio Inc (NASDAQ: RGNX) was 9.61% up from the session before settling in for the closing price of $8.74. A 52-week range for RGNX has been $8.44 – $28.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 72.63% over the past five years. When this article was written, the company’s average yearly earnings per share was at 21.64%. With a float of $44.84 million, this company’s outstanding shares have now reached $49.53 million.
Let’s look at the performance matrix of the company that is accounted for 344 employees. In terms of profitability, gross margin is 39.46%, operating margin of -289.09%, and the pretax margin is -283.37%.
Regenxbio Inc (RGNX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Regenxbio Inc stocks. The insider ownership of Regenxbio Inc is 9.50%, while institutional ownership is 90.27%. The most recent insider transaction that took place on Oct 01 ’24, was worth 101,052. In this transaction Director of this company sold 10,000 shares at a rate of $10.11, taking the stock ownership to the 11,286 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Director sold 10,000 for $11.56, making the entire transaction worth $115,588. This insider now owns 11,286 shares in total.
Regenxbio Inc (RGNX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.64% per share during the next fiscal year.
Regenxbio Inc (NASDAQ: RGNX) Trading Performance Indicators
You can see what Regenxbio Inc (RGNX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.03, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -0.72 in one year’s time.
Technical Analysis of Regenxbio Inc (RGNX)
Regenxbio Inc (NASDAQ: RGNX) saw its 5-day average volume 1.22 million, a positive change from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 28.45%. Additionally, its Average True Range was 0.80.
During the past 100 days, Regenxbio Inc’s (RGNX) raw stochastic average was set at 16.47%, which indicates a significant decrease from 38.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.37% in the past 14 days, which was higher than the 68.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.82, while its 200-day Moving Average is $13.85. Nevertheless, the first resistance level for the watch stands at $9.99 in the near term. At $10.40, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.10. If the price goes on to break the first support level at $8.88, it is likely to go to the next support level at $8.18. The third support level lies at $7.77 if the price breaches the second support level.
Regenxbio Inc (NASDAQ: RGNX) Key Stats
There are 49,545K outstanding shares of the company, which has a market capitalization of 520.26 million. As of now, sales total 90,240 K while income totals -263,490 K. Its latest quarter income was 24,200 K while its last quarter net income were -59,600 K.
